Chronic Inflammatory Demyelinating Polyradiculoneuropathy

P. Y K Van den Bergh, R. D M Hadden, Pierre Bouche, David Cornblath, A. Hahn, I. Illa, C. L. Koski, J. M. Léger, E. Nobile-Orazio, J. Pollard, C. Sommer, P. A. van Doorn, I. N. van Schaik

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationEuropean Handbook of Neurological Management: Second Edition
PublisherWiley-Blackwell
Pages333-341
Number of pages9
Volume1
ISBN (Print)9781405185332
DOIs
StatePublished - Sep 6 2010

Fingerprint

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Keywords

  • Aim to update EFNS/PNS guideline on management of CIDP-based on newly available evidence
  • Chronic inflammatory demyelinating polyradiculoneuropathy
  • Dearth of evidence, concerning general aspects of treatment for symptoms of CIDP-as pain and fatigue
  • Demyelinating polyradiculoneuropathy-and electrodiagnostic criteria
  • Different sets of diagnostic criteria for CIDP-sensitivity and specificity varying
  • Good Practice Points for defining diagnostic criteria for CIDP-initial management
  • Immunosuppressant and immunomodulatory drugs-beneficial in CIDP (Class IV evidence)
  • Intravenous immunoglobulin-showing that IVIg 2.0 g/kg produces significant improvement in disability lasting 2-6 weeks
  • No evidence-based guideline-as none of trials, systematically assessed long-term management
  • Supportive features for diagnosis of CIDP-macrophage-associated demyelination, onion bulb formation, demyelinated and remyelinated nerve fibres

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Van den Bergh, P. Y. K., Hadden, R. D. M., Bouche, P., Cornblath, D., Hahn, A., Illa, I., ... van Schaik, I. N. (2010). Chronic Inflammatory Demyelinating Polyradiculoneuropathy. In European Handbook of Neurological Management: Second Edition (Vol. 1, pp. 333-341). Wiley-Blackwell. https://doi.org/10.1002/9781444328394.ch20

Chronic Inflammatory Demyelinating Polyradiculoneuropathy. / Van den Bergh, P. Y K; Hadden, R. D M; Bouche, Pierre; Cornblath, David; Hahn, A.; Illa, I.; Koski, C. L.; Léger, J. M.; Nobile-Orazio, E.; Pollard, J.; Sommer, C.; van Doorn, P. A.; van Schaik, I. N.

European Handbook of Neurological Management: Second Edition. Vol. 1 Wiley-Blackwell, 2010. p. 333-341.

Research output: Chapter in Book/Report/Conference proceedingChapter

Van den Bergh, PYK, Hadden, RDM, Bouche, P, Cornblath, D, Hahn, A, Illa, I, Koski, CL, Léger, JM, Nobile-Orazio, E, Pollard, J, Sommer, C, van Doorn, PA & van Schaik, IN 2010, Chronic Inflammatory Demyelinating Polyradiculoneuropathy. in European Handbook of Neurological Management: Second Edition. vol. 1, Wiley-Blackwell, pp. 333-341. https://doi.org/10.1002/9781444328394.ch20
Van den Bergh PYK, Hadden RDM, Bouche P, Cornblath D, Hahn A, Illa I et al. Chronic Inflammatory Demyelinating Polyradiculoneuropathy. In European Handbook of Neurological Management: Second Edition. Vol. 1. Wiley-Blackwell. 2010. p. 333-341 https://doi.org/10.1002/9781444328394.ch20
Van den Bergh, P. Y K ; Hadden, R. D M ; Bouche, Pierre ; Cornblath, David ; Hahn, A. ; Illa, I. ; Koski, C. L. ; Léger, J. M. ; Nobile-Orazio, E. ; Pollard, J. ; Sommer, C. ; van Doorn, P. A. ; van Schaik, I. N. / Chronic Inflammatory Demyelinating Polyradiculoneuropathy. European Handbook of Neurological Management: Second Edition. Vol. 1 Wiley-Blackwell, 2010. pp. 333-341
@inbook{c5f073b99f704cb696f5843d7ed54276,
title = "Chronic Inflammatory Demyelinating Polyradiculoneuropathy",
keywords = "Aim to update EFNS/PNS guideline on management of CIDP-based on newly available evidence, Chronic inflammatory demyelinating polyradiculoneuropathy, Dearth of evidence, concerning general aspects of treatment for symptoms of CIDP-as pain and fatigue, Demyelinating polyradiculoneuropathy-and electrodiagnostic criteria, Different sets of diagnostic criteria for CIDP-sensitivity and specificity varying, Good Practice Points for defining diagnostic criteria for CIDP-initial management, Immunosuppressant and immunomodulatory drugs-beneficial in CIDP (Class IV evidence), Intravenous immunoglobulin-showing that IVIg 2.0 g/kg produces significant improvement in disability lasting 2-6 weeks, No evidence-based guideline-as none of trials, systematically assessed long-term management, Supportive features for diagnosis of CIDP-macrophage-associated demyelination, onion bulb formation, demyelinated and remyelinated nerve fibres",
author = "{Van den Bergh}, {P. Y K} and Hadden, {R. D M} and Pierre Bouche and David Cornblath and A. Hahn and I. Illa and Koski, {C. L.} and L{\'e}ger, {J. M.} and E. Nobile-Orazio and J. Pollard and C. Sommer and {van Doorn}, {P. A.} and {van Schaik}, {I. N.}",
year = "2010",
month = "9",
day = "6",
doi = "10.1002/9781444328394.ch20",
language = "English (US)",
isbn = "9781405185332",
volume = "1",
pages = "333--341",
booktitle = "European Handbook of Neurological Management: Second Edition",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Chronic Inflammatory Demyelinating Polyradiculoneuropathy

AU - Van den Bergh, P. Y K

AU - Hadden, R. D M

AU - Bouche, Pierre

AU - Cornblath, David

AU - Hahn, A.

AU - Illa, I.

AU - Koski, C. L.

AU - Léger, J. M.

AU - Nobile-Orazio, E.

AU - Pollard, J.

AU - Sommer, C.

AU - van Doorn, P. A.

AU - van Schaik, I. N.

PY - 2010/9/6

Y1 - 2010/9/6

KW - Aim to update EFNS/PNS guideline on management of CIDP-based on newly available evidence

KW - Chronic inflammatory demyelinating polyradiculoneuropathy

KW - Dearth of evidence, concerning general aspects of treatment for symptoms of CIDP-as pain and fatigue

KW - Demyelinating polyradiculoneuropathy-and electrodiagnostic criteria

KW - Different sets of diagnostic criteria for CIDP-sensitivity and specificity varying

KW - Good Practice Points for defining diagnostic criteria for CIDP-initial management

KW - Immunosuppressant and immunomodulatory drugs-beneficial in CIDP (Class IV evidence)

KW - Intravenous immunoglobulin-showing that IVIg 2.0 g/kg produces significant improvement in disability lasting 2-6 weeks

KW - No evidence-based guideline-as none of trials, systematically assessed long-term management

KW - Supportive features for diagnosis of CIDP-macrophage-associated demyelination, onion bulb formation, demyelinated and remyelinated nerve fibres

UR - http://www.scopus.com/inward/record.url?scp=84885489018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885489018&partnerID=8YFLogxK

U2 - 10.1002/9781444328394.ch20

DO - 10.1002/9781444328394.ch20

M3 - Chapter

AN - SCOPUS:84885489018

SN - 9781405185332

VL - 1

SP - 333

EP - 341

BT - European Handbook of Neurological Management: Second Edition

PB - Wiley-Blackwell

ER -